Literature DB >> 147657

[Clinical and biochemical studies in three pregnancies with placental sulphatase deficiency (author's transl)].

W D Lehmann, A S Wolf, C Lauritzen.   

Abstract

Three pregnancies (two I. parae and one II. para) with abnormally low urinary estrogen excretion of less than 5 mg estrogens per day have been investigated in this study. After intravenous injection of 100 mg DHA-S to the mothers no increase of estrogen production was observed. The level of human placental lactogen, was found within normal range. Ultrasonographic measurement of fetal size and monitoring of the fetal heart rate have demonstrated fetal benefit. At the end of pregnancy the cervix of both did not dilate after infusion of Syntocinon. Healthy male infants were delivered by Caesarean sections in both cases. The II. para, however, developed spontaneous labour and delivery at term. Clinical and laboratory tests have indicated the possibility of rare placental sulphatase deficiency. After delivery the placental steroid sulphatase activity was measured as the rate of hydrolysis of (6,7-3H) oestrone-sulphate or (4-14C) dehydroepiandrosterone-sulphate during in vitro incubation with the homogenate or the microsomal fraction from the pathological placentae. In all three cases the specific activity of 3-sulphatase was considerably (more than 80%) decreased when compared to three normal placentas, whereas the activity of the other enzymes (17beta-hydroxysteroidoxidoreductase, delta4/5-isomerase, aromatizing enzyme system) was found within the normal range.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 147657     DOI: 10.1007/bf00672832

Source DB:  PubMed          Journal:  Arch Gynakol        ISSN: 0003-9128


  9 in total

1.  [Paper chromatography of phenol steroids].

Authors:  R KNUPPEN
Journal:  Int Z Vitaminforsch Beih       Date:  1963-02-20

2.  Steroid sulfatase in the human pacenta.

Authors:  J C WARREN; C E TIMBERLAKE
Journal:  J Clin Endocrinol Metab       Date:  1962-11       Impact factor: 5.958

3.  Urinary oestrogen and plasma human placental lactogen as initial screening tests for a placental sulphatase deficiency.

Authors:  G H Beastall; A M Kelly; P England; L G Rao; M W MacGregor; M L Paterson
Journal:  Scott Med J       Date:  1976-07       Impact factor: 0.729

4.  [Characterization and kinetics of a microsomal 17-beta-hydroxysteroid oxidoreductase from human placenta].

Authors:  W D Lehmann; H Breuer
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1967-12

5.  Biochemical and clinical observations a pregnancy with placental sulphatase and other enzyme deficiencies.

Authors:  R E Oakey; M L Cawood; R R Macdonald
Journal:  Clin Endocrinol (Oxf)       Date:  1974-04       Impact factor: 3.478

6.  In vitro conversion of (4-14C) dehydroepiandrosterone and androstenedione to oestrogens by the microsomes of placentas from normal, toxaemic, diabetic and postmature pregnancies.

Authors:  W D Lehmann; C Lauritzen; R Schumann
Journal:  Acta Endocrinol (Copenh)       Date:  1973-08

7.  A study of pregnancy with low estrogen production due to placental sulfatase deficiency.

Authors:  J T France; R J Seddon; G C Liggins
Journal:  J Clin Endocrinol Metab       Date:  1973-01       Impact factor: 5.958

8.  Low urinary oestriol excretion during pregnancy associated with placental sulphatase deficiency or congenital adrenal hypoplasia.

Authors:  J R Fliegner; I Schindler; J B Brown
Journal:  J Obstet Gynaecol Br Commonw       Date:  1972-09

9.  [Paradoxal estrogen deficiency caused by placental sulfatase deficiency in a normal pregnancy].

Authors:  L Cedard; C Tchobrousky; R Guglielmina; M Mailhac
Journal:  Bull Fed Soc Gynecol Obstet Lang Fr       Date:  1971 Jan-Mar
  9 in total
  2 in total

Review 1.  Review: genetics of steroid sulphatase deficiency and X-linked ichthyosis.

Authors:  M A Crawfurd
Journal:  J Inherit Metab Dis       Date:  1982       Impact factor: 4.982

2.  Placental steroid metabolism in a case of placental sulfatase deficiency.

Authors:  H Gips; P Bailer; K Korte
Journal:  J Endocrinol Invest       Date:  1980 Jan-Mar       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.